Stocks · Health care · Biological Products, (No Diagnostic Substances)

Passage BIO, Inc.

PASG Clue Score25
United States Fiscal year ends December CIK 0001787297 Results filed 3 Mar 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Orbimed Advisors LLC
26 Jun 2025
10% owner
Sell indirect
213,257
$0.33
$70.37K
Orbimed Advisors LLC
25 Jun 2025
10% owner
Sell indirect
138,800
$0.33
$45.80K
Orbimed Advisors LLC
24 Jun 2025
10% owner
Sell indirect
231,600
$0.35
$81.06K
Orbimed Advisors LLC
24 Apr 2025
10% owner
Sell indirect
68,195
$0.32
$21.82K
Orbimed Advisors LLC
23 Apr 2025
10% owner
Sell indirect
89,328
$0.34
$30.37K
Orbimed Advisors LLC
22 Apr 2025
10% owner
Sell indirect
78,049
$0.34
$26.54K
Orbimed Advisors LLC
17 Apr 2025
10% owner
Sell indirect
77,090
$0.33
$25.44K
Orbimed Advisors LLC
16 Apr 2025
10% owner
Sell indirect
61,638
$0.33
$20.34K
Orbimed Advisors LLC
15 Apr 2025
10% owner
Sell indirect
10,326
$0.38
$3.92K
Kathleen Borthwick
11 Feb 2025
CFO
Sell
3,183
$0.53
$1.69K
Orbimed Advisors LLC
14 Jan 2025
10% owner
Sell indirect
79,024
$0.60
$47.41K
Orbimed Advisors LLC
13 Jan 2025
10% owner
Sell indirect
17,986
$0.64
$11.51K
Orbimed Advisors LLC
10 Jan 2025
10% owner
Sell indirect
126,209
$0.66
$83.30K
Orbimed Advisors LLC
8 Jan 2025
10% owner
Sell indirect
75,007
$0.68
$51.00K
Orbimed Advisors LLC
7 Jan 2025
10% owner
Sell indirect
52,536
$0.71
$37.30K
Orbimed Advisors LLC
6 Jan 2025
10% owner
Sell indirect
19,481
$0.77
$15.00K
Orbimed Advisors LLC
20 Dec 2024
10% owner
Sell indirect
230,321
$0.60
$138.19K
Orbimed Advisors LLC
11 Dec 2024
10% owner
Sell indirect
80
$0.80
$64.00
Orbimed Advisors LLC
10 Dec 2024
10% owner
Sell indirect
8,015
$0.80
$6.41K
Orbimed Advisors LLC
9 Dec 2024
10% owner
Sell indirect
54,181
$0.84
$45.51K
Orbimed Advisors LLC
6 Dec 2024
10% owner
Sell indirect
20,903
$0.82
$17.14K
Orbimed Advisors LLC
4 Dec 2024
10% owner
Sell indirect
76,200
$0.79
$60.20K
Orbimed Advisors LLC
19 Sep 2024
10% owner
Sell indirect
39,300
$0.71
$27.90K
Orbimed Advisors LLC
18 Sep 2024
10% owner
Sell indirect
25,631
$0.73
$18.71K
Orbimed Advisors LLC
17 Sep 2024
10% owner
Sell indirect
111,400
$0.73
$81.32K
Orbimed Advisors LLC
16 Sep 2024
10% owner
Sell indirect
63,100
$0.74
$46.69K
Mark S Forman
13 Feb 2024
Chief Medical Officer
Sell
1,638
$0.97
$1.59K
Kathleen Borthwick
13 Feb 2024
SVP, Interim CFO
Sell
1,470
$0.97
$1.43K
Mark S Forman
2 Jan 2024
Chief Medical Officer
Sell
15,813
$0.91
$14.39K
Edgar B. Cale
2 Jan 2024
GC & Corporate Secretary
Sell
15,813
$0.91
$14.39K
Kathleen Borthwick
2 Jan 2024
SVP, Interim CFO
Sell
10,672
$0.91
$9.71K
Alexandros Fotopoulos
16 Jun 2023
Chief Technical Officer
Sell
4,052
$0.93
$3.78K
Sandip Kapadia
1 Dec 2022
Director
Sell
5,000
$1.19
$5.96K
Monika Maria Toernsen
19 Sep 2022
Chief Commercial Officer
Sell
1,681
$1.51
$2.54K
Jill M. Quigley
20 Jan 2021
Chief Operating Officer
Sell
1,300
$30.01
$39.01K
Jill M. Quigley
14 Jan 2021
Chief Operating Officer
Sell
16,298
$30.10
$490.57K

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 23
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 24,273,474
Sales filed before the plan box existed 4
History held since 2 Mar 2020